ClinConnect ClinConnect Logo
Search / Trial NCT06176430

Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy

Launched by SHAHEED ZULFIQAR ALI BHUTTO MEDICAL UNIVERSITY · Dec 9, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Cerebral Palsy, Anemia

ClinConnect Summary

This clinical trial is looking at how effective two different ways of giving iron treatment are for children with cerebral palsy who also have iron deficiency anemia. The researchers want to see if giving iron twice a week works just as well as giving it every day. This study will take place at the pediatric medicine department of the Children’s Hospital in Islamabad.

To be part of this trial, children must be between 6 months and 5 years old and have both cerebral palsy and iron deficiency anemia. Unfortunately, children older than 5, those with very low hemoglobin levels requiring blood transfusions, or those who have taken iron supplements in the last month can't participate. If eligible, children will receive either the twice-weekly or daily iron treatment, and the researchers will monitor how well each method helps improve their anemia. This study aims to find the best way to help these children feel better and improve their health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. All the children with cerebral palsy who are diagnosed cases of iron deficiency anaemia
  • 2. Age 06 months to 5 years
  • 3. Both genders
  • Exclusion Criteria:
  • 1. \>5 years of age
  • 2. Children with severe anaemia requiring transfusion (Hb\<5 g/L)
  • 3. Children with history of taking oral/IV iron supplements or repeated blood transfusions during last one month
  • 4. Children with concomitant diarrheal disease
  • 5. Where parents are not willing to participate in the study

About Shaheed Zulfiqar Ali Bhutto Medical University

Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU) is a premier medical institution dedicated to advancing healthcare through rigorous clinical research and education. Located in Islamabad, Pakistan, SZABMU is committed to fostering innovation and excellence in medical science. The university actively engages in clinical trials that aim to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and patient safety, SZABMU collaborates with a network of healthcare professionals and researchers to ensure the highest quality of research practices, ultimately enhancing the health and well-being of diverse populations.

Locations

Patients applied

0 patients applied

Trial Officials

Yusra Kafait, MBBS

Principal Investigator

Shaheed Zulfiqar Ali Bhutto Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported